Skip to main content

Anhydro-Arabinosyl-Fluorocytosine Hydrochloride: A Phase I Study

  • Chapter
Chemotherapy

Part of the book series: Chemotherapy ((CT,volume 8))

  • 118 Accesses

Abstract

2.2′ -anhydro-1-(B-D-arabinosyl)-5-fluorocytosine hydrochloride (fluorocyclocytidine, AAFC), is a pyrimidine analog with anti-tumor activity in experimental animal tumors. AAFC is hydrolysed to arabinosyl-fluorocytosine wich, as arabinosyl-cytosine, inhibits DNA-polymerase activity. AAFC is also deaminated to arabinosyl-fluorouracil, wich possibly also inhibits thymidilate synthetase.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Press, New York

About this chapter

Cite this chapter

Alberto, P., Medenica, R. (1976). Anhydro-Arabinosyl-Fluorocytosine Hydrochloride: A Phase I Study. In: Hellmann, K., Connors, T.A. (eds) Chemotherapy. Chemotherapy, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4352-3_67

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4352-3_67

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4354-7

  • Online ISBN: 978-1-4613-4352-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics